Market Place
Sourcing Support
Upsher-Smith Presents Rare Disease Portfolio at CNS Annual Meeting
11 Nov 2024 //
PR NEWSWIRE
Upsher Smith`s Generics Deflazacort Receives Approval in US
05 Nov 2024 //
FDA
Upsher-Smith Selects PANTHERx Rare For Distribution Of TORPENZ
20 Aug 2024 //
PR NEWSWIRE
Upsher-Smith Launches TORPENZ™ Tablets For Rare Diseases
05 Aug 2024 //
PR NEWSWIRE
Upsher-Smith Enhances Promise Of Support Program For Rare Diseases
01 Jul 2024 //
PR NEWSWIRE
Upsher-Smith Wins HDA DIANA Award
19 Jun 2024 //
PR NEWSWIRE
Upsher Smith Labs Generic Brimonidine Tartrate Receives Approval in US
12 Jun 2024 //
FDA
Upsher-Smith Named as 2024 Asap Alliance Excellence Award Finalist
14 May 2024 //
PR NEWSWIRE
Upsher-Smith Rare Disease Portfolio At AAN 2024
12 Apr 2024 //
PR NEWSWIRE
Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
02 Apr 2024 //
PRESS RELEASE
Upsher-Smith Launches Methimazole Tablets, USP
29 Mar 2024 //
PR NEWSWIRE
Upsher-Smith and Naspa Announce Excellence In Innovation Award Recipients
06 Feb 2024 //
PR NEWSWIRE
Upsher-Smith Launches Pitavastatin Tablets
06 Nov 2023 //
PR NEWSWIRE
Upsher-Smith Expands Portfolio With Launch of Mesalamine Extended-Release Capsules
21 Aug 2023 //
PR NEWSWIRE
Upsher-Smith Launches Isotretinoin Capsules, Usp
24 Jul 2023 //
PR NEWSWIRE
Upsher-Smith Divests Two Migraine Products
26 Jun 2023 //
PR NEWSWIRE
Tonix Enters into Agreement to Acquire Products from Upsher-Smith Lab
26 Jun 2023 //
GLOBENEWSWIRE
Upsher-Smith Adds Dicyclomine Hydrochloride Capsules, Usp To Its Product Line
16 May 2023 //
PR NEWSWIRE
Upsher-Smith Launches Fluphenazine Hydrochloride Tablets
03 Apr 2023 //
PR NEWSWIRE
UPSHER-SMITH LAUNCHES DICYCLOMINE HYDROCHLORIDE TABLETS
06 Mar 2023 //
PR NEWSWIRE
Upsher-Smith Opens State-of-the-Art Manufacturing Facility
07 Feb 2023 //
CONTRACT PHARMA
TAKU NAKAOKA NAMED CEO OF UPSHER-SMITH LABORATORIES
12 May 2022 //
PRNEWSWIRE
Upsher Smith Labs` Generic Cholestyramine Receives Approval in the U.S.
21 Jan 2022 //
FDA
Upsher Smith`s Generic Silodosin Receives Approval in the U.S.
03 Jan 2022 //
FDA
Upsher Smith Lab`s Generic Isotretinoin Receives Approval In US
21 Sep 2021 //
FDA
Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP
16 Aug 2021 //
PR NEWSWIRE
Upsher-Smith Launches Isotretinoin Capsules
26 Jun 2021 //
PR NEWSWIRE
Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution
27 May 2021 //
PRESS RELEASE
Upsher-Smith Lab Generic Isotretinoin Receives Approval In US
16 Apr 2021 //
FDA
Upsher Smith`s Generic Moxifloxacin Hydrochloride Approved in US
16 Feb 2021 //
FDA
Upsher-Smith Launches Ramelteon Tablets
15 Dec 2020 //
UPSHER-SMITH
Upsher-Smith Supports The American Headache Society`s Virtual 2020
16 Nov 2020 //
PRNEWSWIRE
Upsher Smith Labs`s Generic Doxepin Hydrochloride Receives Approval In US
04 Sep 2020 //
FDA
Upsher Smith`s Generic Ursodiol Approved in US
20 Aug 2020 //
FDA
Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop
07 Aug 2020 //
PRESS RELEASE
Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules
30 Jun 2020 //
PRNEWSWIRE
Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules
30 Jun 2020 //
PRESS RELEASE
Upsher Smith`s Generic Propafenone Hydrochloride Approved in US
30 Jun 2020 //
FDA
Upsher-Smith Offers Help To People With Migraines During National Migraine
23 Jun 2020 //
PRNEWSWIRE
Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration
21 Apr 2020 //
MARKETWATCH
Upsher-Smith Launches Fluvoxamine Maleate Tablets
10 Jan 2020 //
PR NEWSWIRE
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Upsher-Smith Laboratories Launches Tosymra™ (sumatriptan) Nasal Spray
02 Oct 2019 //
PR NEWSWIRE
Enforcement Report - Week of August 28, 2019
28 Aug 2019 //
FDA
Upsher-Smith Launches Morphine Sulfate Tablets
27 Aug 2019 //
PR NEWSWIRE
Acquisition of two treatments ‘rounds out’ Upsher-Smiths migraine portfolio
02 Aug 2019 //
IN-PHARMATECHNOLOGIST
Upsher-Smith Lab`s Generic Morphine Sulfate Receives Approval in US
24 Jul 2019 //
FDA
Dr Reddy`s to sell rights of 2 neurology drugs to Upsher-Smith for $110 mn
14 Jun 2019 //
BUSINESS STANDARD
Upsher-Smith & NASPA Honor U.S. Pharmacists For Their Excellence In Innovation
06 Feb 2019 //
PR NEWSWIRE
Glenmark Pharma gets USFDA nod for seizure treatment drug
25 Jan 2019 //
BUSINESSWIRE
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Upsher-Smith Labs` Generic Clobazam Receives Approval in US
24 Oct 2018 //
FDA
Upsher-Smith Labs` Generic Clobazam Receives Approval in US
24 Oct 2018 //
FDA
Upsher-Smith Labs`s Generic Clonidine Hydrochloride Receives Approval In US
18 Oct 2018 //
FDA
